FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY

Faron Pharmaceuticals Ltd | Company announcement | June 22, 2026 at 16:00:00 EEST

Standard form for notification of major holdings

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FIN-FSA)

1. Identity of the issuer:
FARON PHARMACEUTICALS OY
2. Reason for the notification (please tick the appropriate box or boxes):

☐ An acquisition or disposal of shares or voting rights
☒ An acquisition or disposal of financial instruments
☐ An event changing the breakdown of shares or voting rights
☐ Other (please specify): Click here to enter text.

3. Details of person subject to the notification obligation:
Name:
Bank of America Corporation
City and country of residence:
Wilmington, DE, United States of America
4. Full name of shareholder(s) (if different from 3.):
-
5. Date on which the threshold was crossed or reached:
17.6.2026
6. Total positions of person(s) subject to the notification obligation:

% of shares and voting rights
(total of 7.A)
% of shares and voting rights through financial instruments
(total of 7.B)
Total of both in % (7.A + 7.B)Total number of shares and voting rights of issuer
Resulting situation on the date on which threshold was crossed or reached0.178.738.90227,881,315
Position of previous notification (if applicable)0.129.9910.11

7. Notified details of the resulting situation on the date on which the threshold was crossed or reached:
A: Shares and voting rights
Class/type of
shares
ISIN code (if possible)
Number of shares and voting rights% of shares and voting rights
Direct
(SMA 9:5)
Indirect
(SMA 9:6 and 9:7)
Direct
(SMA 9:5)
Indirect
(SMA 9:6 and 9:7)
FI40001533090377,47800.17
-----
-----
SUBTOTAL A377,478
0.17



B: Financial Instruments according to SMA 9:6a
Type of financial instrumentExpiration
date
Exercise/
Conversion Period
Physical or cash settlementNumber of shares and voting rights% of shares and voting rights
Rights of Usen/an/an/a19,584,4728.59
swaps15/10/2027n/aCash
314,746
0.14
------



SUBTOTAL B19,899,2188.73



8. Information in relation to the person subject to the notification obligation (please tick the applicable box):

☐ Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.

Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity:
Name% of shares and voting rights% of shares and voting rights through financial instrumentsTotal of both
Bank of America Corporation


NB Holdings Corporation


BofAML Jersey Holdings Limited



BofAML EMEA Holdings 2 Limited


ML UK Capital Holdings Limited


Merrill Lynch International


Bank of America Corporation


NB Holdings Corporation


BAC North America Holding Company


Bank of America, National Association


Bank of America Corporation


NB Holding Corporation


Bofa Securities, Inc
8.59%8.59%

9. In case of proxy voting: [name of the proxy holder] will cease to hold [% and number] voting rights as of Click here to enter a date.


10. Additional information:
-


Done at London, United Kingdom on 18.6.2026.


UK 100

Latest directors dealings